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Summary
 
We have demonstrated that intestinal epithelial cells produce interleukin 7 (IL-7), and IL-7
serves as a potent regulatory factor for proliferation of intestinal mucosal lymphocytes express-
ing functional IL-7 receptor. To clarify the mechanism by which locally produced IL-7 regu-
lates the mucosal lymphocytes, we investigated IL-7 transgenic mice. Here we report that
transgenic mice expressing murine IL-7 cDNA driver by the SR
 
a
 
 promoter developed chronic
colitis in concert with the expression of SR
 
a
 
/IL-7 transgene in the colonic mucosa. IL-7 trans-
genic but not littermate mice developed chronic colitis at 4–12 wk of age, with histopatholog-
ical similarity to ulcerative colitis in humans. Southern blot hybridization and competitive
PCR demonstrated that the expression of IL-7 messenger RNA was increased in the colonic
mucosal lymphocytes but not in the colonic epithelial cells. IL-7 protein accumulation was de-
creased in the goblet cell–depleted colonic epithelium in the transgenic mice. Immunohis-
tochemical and cytokine production analysis showed that lymphoid infiltrates in the lamina
propria were dominated by T helper cell type 1 CD4
 
1
 
 T cells. Flow cytometric analysis dem-
onstrated that CD4
 
1
 
 intraepithelial T cells were increased, but T cell receptor 
 
g
 
/
 
d
 
 T cells and
CD8
 
a
 
/
 
a
 
 cells were not increased in the area of chronic inflammation. Increased IL-7 receptor
expression in mucosal lymphocytes was demonstrated in the transgenic mice. These findings
suggest that chronic inflammation in the colonic mucosa may be mediated by dysregulation of
colonic epithelial cell–derived IL-7, and this murine model of chronic colitis may contribute to
the understanding of the pathogenesis of human inflammatory bowel disease.
 
I
 
nterleukin 7 (IL-7) is a stromal cell–derived pleiotropic
cytokine with cell growth–promoting activity of lym-
phoid precursors. IL-7 was originally described as a growth
factor for precursor B cells (1–3). Subsequent in vitro stud-
ies have demonstrated that IL-7 is also a potent costimulus
for immature and mature cells of the T cell lineage (4–8).
Recently IL-7 messenger RNA (mRNA)
 
1
 
 was shown to
be expressed in bone marrow stromal cells, thymus stromal
cells, spleen, liver, kidney, and skin (9, 10). However, a
potential role of IL-7 in peripheral lymphoid tissues re-
mains unclear.
We have demonstrated the IL-7 mRNA expression and
IL-7 protein production in human colonic epithelial cells
(11). Immunohistochemical and in situ hybridization analy-
sis have demonstrated that epithelial goblet cells are the
major source of IL-7 production in the colonic mucosa.
Interactions between mucosal lymphocytes and intestinal
epithelial cells are thought to be crucial for maintaining
mucosal immunity. Intestinal mucosal lymphocytes, in-
cluding both intraepithelial lymphocytes (IELs) and lamina
propria lymphocytes (LPLs), may serve a critical role in the
mucosal immune system by providing immune surveillance
 
1
 
Abbreviations used in this paper:
 
 G3PDH, glyceraldehyde 3-phosphate de-
hydrogenase; IEL, intraepithelial lymphocyte; LPL, lamina propria lym-
phocyte; mRNA, messenger RNA; RT-PCR, reverse transcriptase
PCR.
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of epithelial cells (12–14). However, little is known about
the precise mechanisms by which functional differentiation
and proliferation of these cells occurs in the intestinal mu-
cosa. We have shown that IL-7 receptor is expressed in the
mucosal lymphocytes and intestinal epithelial cells, and in-
testinal epithelial cell–derived IL-7 may serve as a potent
regulatory factor for the proliferation of these cells (11, 15).
The importance of IL-7 as a mediator of local inflamma-
tory responses remains unclear. To clarify the mechanism
by which locally produced IL-7 may affect mucosal lym-
phocyte fraction and the role of IL-7 in colonic inflamma-
tion, we investigated transgenic mice carrying murine IL-7
cDNA and SR
 
a
 
 promoter (16). Here we report that IL-7
transgenic mice develop chronic colitis, in concert with the
expression of SR
 
a
 
/IL-7 transgene in the colonic mucosa.
These findings favor the idea that chronic inflammation in
the colonic mucosa is mediated by a colonic epithelial cell–
derived IL-7.
 
Materials and Methods
 
IL-7 Transgenic Mice.
 
Generation of IL-7 transgenic mice has
been previously described (16). PCR-amplified murine IL-7
cDNA was ligated with SR
 
a
 
 promoter (17) and designated as
SR
 
a
 
/IL-7. 21 founders of SR
 
a
 
/IL-7 transgenic mice were estab-
lished by microinjection method into fertilized eggs of C57 BL6/J
mice, and copy number of the transgene varied from 1 to 30. All
mice were bred and housed under clean conditions with moni-
toring every month to ensure that they were free of specific
pathogens. Transgenic lines were maintained by crossing trans-
genic mice with C57BL/6J mice and screening transgene-posi-
tive siblings by Southern blot analysis of their tail DNA. We used
a founder mouse number 34 and its offspring, with copy number
of transgenes 
 
,
 
10. The line 34 mice developed dermatitis at ear-
lier periods, as previously described (16).
 
Histological and Immunohistological Analysis.
 
The en block–
fixed gastrointestinal tract was dissected into stomach, jejunum
and ileum (small intestine), colon, and rectum. Tissue specimens
were fixed in 10% formalin and embedded in paraffin. Sections
were stained with hematoxylin-eosin. For immunohistochemis-
try, sections were fixed with 2% periodate lysine paraformalde-
hyde and frozen in OCT compound. Staining of sections was
performed by the avidin–biotin complex method. 6 
 
m
 
m sections
were incubated with the primary antibodies. These included anti-
CD4 (L3T4), anti-CD8
 
a
 
 (Ly-2), anti–TCR 
 
a
 
/
 
b
 
 (H57-597), and
anti–
 
d
 
 chain of TCR-
 
g
 
/
 
d
 
 (GL3) (PharMingen, San Diego, CA).
Anti–murine IL-7 IgG mAb (Genzyme Corp., Cambridge, MA),
anti–murine IL-7 receptor antibody (provided by S. Nishikawa,
Kyoto University, Kyoto, Japan), or isotype-matched control
antibody were also used. Biotinylated F(ab)
 
2
 
 fragments of im-
munoaffinity-purified antibodies were used as bridging reagents.
Biotinylated antibodies were detected by immersing the sec-
tions for 40 min in a solution of streptoavidin–enzyme conju-
gates (Vectastain ABC kit; Vector Labs., Inc., Burlingame, CA).
The localization of antigens was visualized by the incubation
with diaminobenzidine solution and counterstained with meth-
ylgreen.
 
PCR and Southern Blotting for Murine IL-7 and IL-7 Receptor
mRNA.
 
Cytoplasmic RNA was prepared from the indicated
tissues using the RNAzol (Biotecx Lab, Houston, TX). First-strand
cDNA was synthesized from 2 
 
m
 
g of total RNA with 1 
 
m
 
g oligo
(dT) primer and 400 U/
 
m
 
l MMLV reverse transcriptase (Perkin
Elmer Cetus, Norwalk, CT) by using SuperScript Preamplifica-
tion System (GIBCO BRL, Gaithersburg, MD) in 20 
 
m
 
l of the
reaction mixture. The sequences for PCR primer to detect SR
 
a
 
/
IL-7 transgene were: 5
 
9
 
 primer: 5
 
9
 
-CTC TAG AAC TAG TGG
ATC CC-3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
-AGC TTC CTT TGT ATC ATC
AC-3
 
9
 
; amplified fragment: 278 bp. Other PCR primers for
murine IL-7, IL-7 receptor, and glyceraldehyde 3-phosphate de-
hydrogenase (G3PDH; as a house keeping gene) gene-specific
amplification of cDNA in the analysis of mRNA expression by
reverse transcription PCR (RT-PCR) were purchased from Clo-
notech (Palo Alto, CA). The sequences for IL-7 PCR primer
were: 5
 
9
 
 primer: 5
 
9
 
-GCC TGT CAC ATC ATC TGA GTG
CC-3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
-CAG GAG GCA TCC AGG AAC TTC
TG-3
 
9
 
; amplified fragment: 496 bp. Primers for IL-7 receptor
were: 5
 
9
 
 primer: 5
 
9
 
-CCC CAT AAC GAT TAC TTC AAA
GGC TTC TGG-3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
-AGA GTT TGG CAG CAA
GTC TTG ATA CAC AGG-3
 
9
 
; amplified fragment: 600 bp.
The sequences for murine IFN-
 
g
 
 PCR primers were: 5
 
9
 
 primer:
5
 
9
 
 TGC ATC TTG GCT TTG CAG CTC TTC CTC ATG
GC-3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
-TGC ACC TGT GGG TTG TTG ACC
TCA AAC TTG GC-3
 
9
 
; amplified fragment: 365 bp. Primers for
IL-4 were: 5
 
9
 
 primer: 5
 
9
 
-CCA GCT AGT TGT CAT CCT
GCT CTT CTT TCT CTC G-3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
-CAG TGA
TGT GGA CTT GGA CTG ATC TTC ATG GTG C-3
 
9
 
; am-
plified fragment: 357 bp. Primers for G3PDH were: 5
 
9
 
 primer:
5
 
9
 
-TGA AGG TCG GTG TGA ACG GAT TTG GC-3
 
9
 
;
3
 
9
 
primer: 5
 
9
 
-CAT GTA GGC CAT GAG GTC CAC CAC-3
 
9
 
;
amplified fragment: 983 bp (mapping amplimers; Clonotech),
used as controls. For PCR, 5 
 
m
 
l of cDNA was amplified in the
presence of 0.5 
 
m
 
M of each of the 5
 
9
 
 and 3
 
9
 
 primers, and 0.5 U of
Taq DNA polymerase (Ampli Tag; Perkin Elmer Cetus). PCR
was performed in a DNA thermal cycler for 30 cycles (94
 
8
 
C for
45 s, 60
 
8
 
C for 45 s, and 72
 
8
 
C for 90 s) followed by a 7-min ex-
tension at 72
 
8
 
C. 9 
 
m
 
l of the PCR products was subjected to elec-
trophoresis on 1.6% agarose gels and stained with 0.5 
 
m
 
g/ml
ethidium bromide. A 100-bp DNA ladder (GIBCO BRL) was
used as a marker. The specificity of the PCR products were vali-
dated by restriction enzyme digestion and Southern blot hybrid-
ization. The amplified IL-7 PCR product (496 bp) was digested
by restriction enzyme EcoRI (10 U/
 
m
 
l; GIBCO BRL) into frag-
ments. The predicted size of two fragments is 263 and 233 bp.
For Southern blot, PCR products on the agarose gels were blot-
ted onto nylon membrane (Biodyne; Pal BioSupport Corp., Glen
Cove, NY), and hybridized with IL-7 gene-specific cDNA oligo-
nucleotide probe (Clonotech) labeled by digoxigenin-dUTP us-
ing the DIG oligonucleotide 3
 
9
 
-end labeling kit (Boehringer
Mannheim, Indianapolis, IN). The sequence for murine IL-7 probe
was: 5
 
9
 
-TGT GAT ACT GTT AGT AAG TGG ACA TTG
AAT-3
 
9
 
 (870–841). Hybridizations were done at 42
 
8
 
C for 18 h
in a solution containing 50% formamide, 5
 
3
 
 SCC, 0.02% SDS,
0.1% 
 
N
 
-lauroyl sarcosine, and heat-denatured DIG-11-dUTP probe
at 10 ng/ml. Blots were washed at a final stringency of 2
 
3
 
 SSC at
68
 
8
 
C and processed for detection of digoxigenin-labeled oligonu-
cleotide probes by enzyme-linked immunoassay (antidigoxigenin
antibody linked to alkaline phosphatase) using the DIG nucleic
acid detection kit (Boehringer Mannheim), according to the
manufacturer’s instructions. Subsequently, the membrane was
equilibrated and then placed in a dark box containing luminogen
PPD. The membrane was incubated for 2 h at 37
 
8
 
C and exposed
for 15 min at room temperature. Negative controls (no DNAs)
were incubated in each experiment and samples were run con-
currently with control samples. 
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Quantitative PCR for Murine IL-7 mRNA Using MIMIC cDNA
Construct. Quantitative analysis was conducted by competitive
PCR by using stepwise dilutions of competitor primer pairs as a
template (PCR MIMICS; Clonotech). Two rounds of PCR am-
plification were performed. In the first PCR reaction, two com-
posite primers were used. The first PCR primers were: 59 primer:
59-GCC TGT CAC ATC ATC TGA GTG CCC GCA AGT
GAA ATC TCC TCC G-39; 39 primer: 59-CAG GAG GCA
TCC AGG AAC TTC TGG GGA CAA GAT ACT CAT CTG
C-39. Each composite primer has the target gene primer sequence
attached to a short, 20-nucleotide stretch of sequence designed to
hybridize to opposite strands of a heterologous DNA fragment.
The desired primer sequences were thus incorporated during the
PCR amplification. A dilution of the first PCR reaction was then
amplified again using only the gene-specific primers. The size of
the MIMIC was 340 bps. The yield of PCR MIMIC was then
calculated and diluted to 100 attomole/ml. cDNA derived from 2 mg
of total RNA was then amplified in the presence of 10-fold serial
dilutions of the IL-7 MIMIC. The amount of change in IL-7
mRNA could be estimated by visually noting how much more of
the MIMIC must be added to achieve an equimolar amount of
product.
Preparation of Mucosal Lymphocytes and Intestinal Epithelial Cells
from the Intestinal Mucosa. We used a modification of previously
established method for the isolation of mouse colonic IELs and
epithelial cells (18). Intestine free of the lumen content was
turned inside-out with the aid of polyethylene tubing. The in-
verted intestine was fastened to the tubing with a string and then
cut into three to four segments. Up to 10 segments of intestines
were transferred to a plastic box containing 250 ml of RPMI
1640 medium (2% FCS, 25 mM Hepes, 100 U/ml of penicillin,
100 mg/ml of streptomycin), and the box was shaken at 378C for
45 min (150 rpm). Cell suspensions were collected in 250-ml
tubes and further processed for the purification of IELs according
to standard technique. In brief, the cell suspension was first passed
through a glass wool column to deplete cell debris and sticky
cells, and then subjected to Percoll discontinuous gradient cen-
trifugation. After centrifugation, cells at the top of the 30% per-
coll solution were found to be enriched with colonic epithelial
cells devoid of CD31 cells. More than 90% of IELs were recov-
ered at the interface of 44 and 70% percoll solutions. This new
method yields IELs with minimum contamination by lympho-
cytes from Peyer’s patches or lamina propria, and villus structure
(lamina propria) without epithelium remained intact after each
isolation. For isolation of LPLs from colon, mesenteric tissues and
Peyer’s patches were removed from intestines that were then cut
open longitudinally, washed with PBS, and cut into smaller
pieces. The dissected mucosa was incubated with Ca21 Mg21-free
Hank’s BSS containing 1 mM dithiothreitol (Sigma Chemical
Co., St. Louis, MO) to remove mucus. The mucosa was then in-
cubated four times in medium containing 0.75 mM EDTA
(Sigma Chemical Co.). The supernatants from these incubations
containing IEL population and LPLs were collected and incu-
bated in medium with 0.02% collagenase (Worthington Biomed-
ical Co., Freehold, NJ) and 0.01% DNase (Worthington Bio-
medical Co.). The fraction was pelleted twice through a 40%
isotonic Percoll solution and the cells were centrifuged over Fi-
coll-Hypaque density gradient. The purity of resulting IELs and
LPLs was analyzed by flow cytometry. Cell preparations were ad-
equately pure, since a/b T cells made up 82–96% of the CD31
cells in LPLs. Enriched CD41 T cell populations were obtained
by negative selection using mouse CD41 T cell isolation columns
(Isocell; Pierce Chemical Co., Rockford, IL).
Estimation of IL-7 Protein Production in Culture Supernatants of Co-
lonic Epithelial Cells and Infiltrating Mucosal Lymphocytes. IL-7 protein
production by epithelial cells and infiltrating mucosal lympho-
cytes expressing IL-7 mRNA was measured by the proliferation
assay of an IL-7–dependent cell line DW34 (17). Freshly isolated
colonic epithelial cells, IELs and LPLs (5 3 106) were cultured in
RPMI 1640 medium supplemented with fetal calf serum for 48 h.
DW34 (104) cells were incubated with culture supernatants of
those cells and cultured for 48 h. The cells were pulsed with 18.5
kBq of [3H]thymidine and harvested for radioactivity. The cul-
ture supernatants of colonic epithelial cells, IELs, and LPLs were
treated with 10 mg/ml of mouse anti–human/mouse IL-7 mAb
(Genzyme Corp.) or isotype-matched mouse Ig for 1 h before the
application to DW34 cells, and concentrated using Centricon.
Serial dilution (0–100 pg/ml) of rIL-7 (Genzyme Corp.) was used
to calibrate IL-7 concentration.
Estimation of Cytokine Production in Culture Supernatants of Infil-
trating Mucosal Lymphocytes. Estimation of cytokine production
in culture supernatants of infiltrating mucosal lymphocytes was
assessed as previously described (19). To measure cytokine pro-
duction, 24-well plates were coated with 10 mg/ml murine anti-
CD3 antibody (clone 145-2C11; PharMingen) overnight at 48C.
Lamina propria CD41 T cells (105) were then cultured in 1 ml of
complete medium in precoated or uncoated wells, and 1 mg/ml
soluble anti-CD28 antibody (clone 37.51; PharMingen) was added
to the anti-CD3 antibody-coated wells. Culture supernatants
were removed after 48 h and assayed for cytokine concentration.
Cytokine concentrations were determined by specific ELISA kit
for mouse IFN-g, IL-2, and IL-4 (Endogen, Inc., Cambridge, MA).
Optical densities were measured on an Intermet ELISA reader at
a wavelength of 490 nm.
Flow Cytometry. mAbs used included anti-CD3, anti-CD4,
anti-CD8a, anti-CD8b (Ly-3.2), anti–TCR-a/b, and anti–d chain
of TCR-g/d (PharMingen). Flow cytometric two-color analysis
carried out as described using the FACScanÒ (Becton Dickinson,
Mountain View, CA). The data were presented as percentages of
positive cells normalized to the number of total T (CD31) cells
and relative mean fluorescence. Background fluorescence was as-
sessed by staining with control irrelevant isotype-identical mAbs.
Results
Development of Acute Colitis in the IL-7 Transgenic Mice.
IL-7 transgenic mice developed acute colitis with infiltrat-
ing neutrophils and lymphocytes at 1–3 wk of age (Fig. 1,
A and B). At 1–3 wk of age when mice developed acute
colitis, the SRa/IL-7 transgene and IL-7 mRNA expres-
sion in the colonic mucosa was revealed in the IL-7 trans-
genic mice (Fig. 1 C). IL-7 protein was also significantly
expressed in the inflamed colonic mucosa of IL-7 trans-
genic mice (Fig. 1 D). Infiltrating T cells in the acute colitis
lesion were CD41 (Fig. 1 E) and T cell receptor g/d T
cells in the IL-7 transgenic mice (Fig. 1 F).
Development of Chronic Colitis in the IL-7 Transgenic
Mice. In the IL-7 transgenic founder number 34 and their
progenies, diarrhea, weight loss, rectal prolapse, and remit-
tent intestinal bleeding was observed frequently at 6–10 wk
of age (Fig. 2). The fact that plural and independent SRa/
IL-7 transgenic lines developed rectal prolapse indicates
that this phenomenon was caused by the transgene itself
and not by the positional effect of the transgene insertion392 IL-7 Transgenic Mice Develop Chronic Colitis
on chromosome. Wide time lags of 4–12 wk of age were
observed for the onset of colitis in the mice. The final cu-
mulative frequencies of colitis in the line 34 mice were
z60% at 16 wk of age. Although several other lines of
mice have developed rectal prolapse, the line 34 mice de-
veloped it at earlier periods and at high frequency. There-
fore, the line 34 mice were used in the subsequent study.
At 4–12 wk of age, histopathological examination of the
colonic tissues revealed the development of chronic colitis
in the IL-7 transgenic mice. Erosions and neutrophil infil-
tration were observed in the anal ring, but no ulceration
was demonstrated (Fig. 3 A). The inflammatory cell infil-
tration and goblet cell depletion was most prominent in the
rectum (Fig. 3 B), but observed throughout entire colon
(Fig. 3, C and D). Crypt abscess (Fig. 3 E), paneth cell
metaplasia (Fig. 3 F), and infiltration of eosinophils were
Figure 1. Transgenic mice carrying murine IL-7 cDNA by the SRa promoter developed acute colitis
with infiltrating neutrophils and lymphocytes at 1–3 wk of age (A and B). At that time, the SRa/IL-7
transgene and IL-7 mRNA expression in the colonic mucosa was revealed (C). IL-7 protein was also
significantly expressed in the inflamed colonic mucosa of IL-7 transgenic mice (D). Infiltrating T cells in
the acute colitis lesion were mainly CD41 T cells (E) and T cell receptor g/d T cells (F).
Figure 2. A line 34 transgenic mice carrying murine IL-7 cDNA by
the SRa promoter developed rectal prolapse at 6 wk (A) and 10 wk (B).
The IL-7 transgenic line 34 mice frequently showed rectal prolapse and
remittent intestinal bleeding at 6–10 wk of age, suggesting the develop-
ment of chronic colitis.393 Watanabe et al.
observed in the lesions (Fig. 3 G). These features resembled
the histopathological characteristics of ulcerative colitis in
humans (20, 21). In contrast, control wild-type mice did
not develop chronic intestinal inflammation at all.
SRa/IL-7 Transgene mRNA Expression in the Inflamed
Colonic Mucosa of IL-7 Transgenic Mice. In the IL-7 trans-
genic mice, 278-bp PCR amplified products of mRNA from
the SRa/IL-7 transgene were expressed in the colonic mu-
cosa. Interestingly, the SRa/IL-7 transgene expression in
the colonic mucosa was parallel with development of chronic
colitis in the IL-7 transgenic mice. SRa/IL-7 transgene
was expressed in the colonic mucosa of transgenic mice with
chronic colitis at both 4 and 8 wk, but not expressed in the
colonic mucosa of mice without colitis at 4 and 8 wk (Fig.
4  A). In the colitis lesion of transgenic mice, SRa/IL-7
transgene was expressed in the colonic epithelial cells, IELs,
and LPLs (Fig. 4 B). The transgene was constitutively ex-
pressed in the thymus, spleen, kidney, brain, lung, and skin,
but not in the liver and muscle as previously reported (17).
IL-7 mRNA Expression in the Colonic Mucosa of Normal
Mice and IL-7 Transgenic Mice. RT-PCR analysis demon-
strated IL-7 mRNA expression in normal murine colonic
tissues (Fig. 5). The specificity of amplified bands was vali-
dated by their predicted size (496 bp). To ensure the pres-
ence of the correct predicted fragments, we digested the
amplified IL-7 PCR product by restriction enzyme EcoRI.
As shown in Fig. 5 A, 496-bp PCR products from murine
colonic mucosa was digested into two predicted fragments
with 263 and 233 bp. Southern blot analysis confirmed ex-
pression of IL-7 mRNA in normal murine colonic mucosa
(Fig. 5 B). IL-7 mRNA expression was detected in the co-
lon as well as the small intestine and stomach tissues.
Equivalent hybridization was observed in Southern blot
analysis using cDNA prepared from five separate sets of tis-
sue samples.
Overexpression of IL-7 mRNA in the Colonic Mucosal Lym-
phocytes but not in the Colonic Epithelial Cells in the Inflamed
Colonic Mucosa of IL-7 Transgenic Mice. To assess the change
of IL-7 mRNA expression in the transgenic mice, we per-
formed competitive PCR analysis for various tissues. As
shown in Fig. 6, competitive PCR demonstrated that
about a 100-fold increase in IL-7 mRNA transcripts was
detected in the inflamed colonic mucosa of the IL-7 trans-
genic mice. In contrast, no difference of the IL-7 mRNA
expression was observed in the thymus tissues between wild-
type mice and IL-7 transgenic mice. We also detected in-
creased IL-7 mRNA in the small intestine with ileitis, but
the expression was quite weak compared to that in the co-
lon with inflammation (data not shown). However, no dif-
ference of the IL-7 mRNA expression was observed in the
colonic and small intestinal mucosa where no inflammation
was observed. These data demonstrate that increased IL-7
mRNA expression occurs in the inflammation site of the
intestinal tissues in IL-7 transgenic mice.
To assess the distribution of increased IL-7 mRNA in
the inflamed colonic tissues, we examined the differential
expression of IL-7 mRNA between the colonic epithelial
cells and colonic mucosal lymphocytes. Colonic IELs and
LPLs isolated from the inflamed colonic tissues of IL-7 trans-
genic mice expressed a significant amount of IL-7 mRNA
(Fig. 7 A). However, IELs and LPLs from the colonic tis-
sues of littermate mice showed no expression of IL-7 mRNA.
Moreover, competitive PCR analysis demonstrated that
IL-7 mRNA expression in the colonic epithelial cells was
not changed in transgenic mice (Fig. 7 B). These indicated
that increased IL-7 expression in the inflamed colonic mu-
cosa of IL-7 transgenic mice was derived from overexpres-
sion of IL-7 mRNA in infiltrated mucosal lymphocytes,
but not in the colonic epithelial cells. It is important to as-
sess the correlation between the development of colitis and
IL-7 mRNA expression in the colonic tissues. Increased
IL-7 mRNA was observed in the colonic mucosa at 2 wk
of age. However, the onset of colitis was at as early as 4 wk
of age.
IL-7 Protein Expression and Production in the Inflamed Colonic
Mucosa of IL-7 Transgenic Mice. To clarify whether increased
IL-7 mRNA expression in the colonic mucosa of trans-
genic mice led to the local overproduction of IL-7 protein,
immunohistochemical analysis using an anti–IL-7 antibody
was done in the colonic mucosa. As shown in Fig. 8 A, IL-7
protein expression was demonstrated in the colonic epithe-
lial cells and epithelial goblet cells in the colonic mucosa of
normal mice. IL-7 protein expression was not changed in
the colonic mucosa of IL-7 transgenic mice at 4–6 wk of
age (data not shown). However, IL-7 protein expression
seemed to be decreased in the goblet-depleted colonic epi-
thelial cells in the chronic inflamed colonic mucosa at 8–10
wk of age (Fig. 8 B).
Our previous study indicated that IL-7 protein expres-
sion by immunohistochemical technique was demonstrated
only in the tissue where secreted IL-7 protein was stored
and accumulated (11). Therefore, IL-7 protein production
by isolated epithelial cells and infiltrating mucosal lympho-
cytes expressing IL-7 mRNA was assessed in the prolifera-
tion assay of an IL-7–dependent cell line DW34. Isolated
epithelial cells, IELs, and LPLs from the inflamed colonic
mucosa of IL-7 transgenic mice produced an increased
amount of IL-7 (data not shown). These results indicated
that IL-7 production was not decreased in the inflamed co-
lonic mucosa of IL-7 transgenic mice in parallel with the
increase of IL-7 mRNA, but accumulation of IL-7 protein
in the colonic mucosa was decreased in the goblet cell–
depleted epithelial cells.
The Infiltrating Cells in the Inflamed Colonic Mucosa Consist
of CD4-positive T Cells in IL-7 Transgenic Mice. The phe-
notype of the infiltrating cells was analyzed by immunohis-
tochemistry and flow cytometry. As shown in Fig. 9, lym-
phoid infiltrates in the lamina propria at the colitis lesion
were dominated by T cells bearing CD4. Both TCR-a/b
T cells and -g/d T cells infiltrated in the lamina propria of
colonic mucosa (data not shown). However, g/d intraepi-
thelial T cells were not increased at the chronic colitic le-
sion (Fig. 10), though g/d T cells were the main compo-
nents of mononuclear cells infiltrating at the dermatitis
lesion of IL-7 transgenic mice as previously reported (17).
Flow cytometric analysis of isolated cells from intraepithe-394 IL-7 Transgenic Mice Develop Chronic Colitis
lium demonstrated that CD41 T cells, but not CD81 T
cells were significantly increased at the colitis lesions. Infil-
trating CD81 intraepithelial T cells mainly expressed the
a/b heterodimer, indicating that these cells were thymus
dependent (Fig. 10).
To assess the phenotype of infiltrating lamina propria
CD41 T cells in the chronic inflamed colonic mucosa of
IL-7 transgenic mice, we examined CD45RB expression,
cytokine mRNA expression, and protein production by
these CD41 T cells. Flow cytometric analysis of isolated
cells from the intestinal mucosa demonstrated that either
CD45RBhigh CD41 or CD45RBlow CD41 lamina propria
Figure 3. Histopathological examination (hematoxylin-eosin staining) of the colonic tissues revealed the development of chronic colitis in the IL-7
transgenic mice. Erosions and neutrophil infiltration were observed in the anal ring (original magnification: 100, A). The inflammatory cell infiltration
and goblet cell depletion was most prominent in the rectum (original magnification: 200, B), but observed diffusely in the entire colon (original magnifi-
cation: 100, C; original magnification: 200, D). Crypt abscess (original magnification: 200, E), paneth cell metaplasia (original magnification: 200, F), and
infiltration of eosinophils (original magnification: 200, G) was observed in the lesions. These mimicked some histopathological characteristics of ulcer-
ative colitis in humans.395 Watanabe et al.
T cells were not significantly increased in the IL-7 trans-
genic mice (data not shown). We also performed PCR
analysis of the homogenates of the chronic inflamed co-
lonic mucosa to assess cytokine mRNA expression, but did
not find the changes in IFN-g mRNA expression and IL-4
mRNA expression in the IL-7 transgenic mice (data not
shown). We then examined cytokine protein production
by isolated cells from the chronic inflamed colonic mucosa.
Isolated cells were cultured and culture supernatants were
analyzed for concentration of Th1 (IL-2, IFN-g) and Th2
(IL-4) cytokines by specific ELISA. Unstimulated lamina
propria CD41 T cells from IL-7 transgenic mice and nor-
mal littermate mice produced marginal amounts of both
IL-2 and IFN-g. Interestingly, isolated lamina propria CD41
T cells from the inflamed colonic mucosa of IL-7 trans-
genic mice produced significantly higher levels of both IL-2
and IFN-g than lamina propria CD41 T cells from litter-
mate mice after stimulation with anti-CD3 and anti-CD28
mAbs (Fig. 11, A and B). In contrast to Th1 type cytokine
production, secretion of IL-4 by unstimulated lamina pro-
pria CD41 T cells from IL-7 transgenic mice was identical
to lamina propria CD41 T cells from littermate mice, and
in anti-CD3 and anti-CD28 mAb-stimulated lamina pro-
pria CD41 T cells from IL-7 transgenic mice, the average
secretion of IL-4 was reduced compared with littermate
mice (Fig. 11 C).
Increased IL-7 Receptor Expression in the Inflamed Colonic
Mucosa of IL-7 Transgenic Mice. To assess the effect of de-
creased IL-7 protein expression in the proliferation of infil-
trating mucosal lymphocytes, IL-7 receptor mRNA ex-
pression was analyzed in the colonic mucosa. Southern blot
analysis demonstrated that IL-7 receptor mRNA was not
readily detectable in the colonic mucosa from wild-type
mice. However, IL-7 receptor expression was strongly de-
tected in the inflamed colonic mucosa of transgenic mice
(Fig. 12). Receptor expression was not strong in the co-
lonic mucosa of transgenic mice without obvious inflam-
mation. Immunohistochemical analysis demonstrated that
IL-7 receptor was mainly expressed in the colonic mucosal
lymphocytes. There was no difference in the expression of
IL-7 receptor in the thymus between IL-7 transgenic mice
and wild-type mice (data not shown).
Discussion
IL-7 is a growth factor for both murine and human, T
cell lineage cells. In the mouse, abundant IL-7 mRNA ex-
pression has been demonstrated in bone marrow stroma,
Figure 4. The expression of
SRa/IL-7 transgene in the co-
lonic mucosa. In the IL-7 trans-
genic mice, 278-bp PCR ampli-
fied products of mRNA from
the SRa/IL-7 transgene were
expressed in the colonic mucosa.
The SRa/IL-7 transgene ex-
pression in the colonic mucosa is
parallel with development of
colitis in the IL-7 transgenic
mice. SRa/IL-7 transgene was
expressed in the colonic mucosa
of transgenic mice with colitis at
both 4 and 8 wk, but not ex-
pressed in the colonic mucosa of
mice without colitis at 4 and 8 wk (A). In the colitis lesion of transgenic mice, SRa/IL-7 transgene was expressed in the colonic epithelial cells (EC),
IELs, and LPLs (B). In contrast, the transgene was constitutively expressed in the thymus, spleen, kidney, brain, lung, and skin, but not in the liver and
muscle as previously reported (data not shown).396 IL-7 Transgenic Mice Develop Chronic Colitis
thymus, spleen, liver, kidney, and keratinocytes (1, 9, 10).
Recent studies have shown that IL-7 is expressed in human
thymus, spleen, and keratinocytes (7–9), although a poten-
tial role of IL-7 in peripheral lymphoid tissues remains un-
clear. We have demonstrated that human intestinal epithe-
lial cells produce IL-7 that serves as a regulatory factor for
proliferation of intestinal mucosal lymphocytes expressing
functional IL-7 receptor (11, 15). In this study, we demon-
strated the presence of epithelial cell–derived IL-7 in the
normal murine intestine.
To clarify the mechanism by which intestinal epithelial
cell-derived IL-7 regulates the mucosal lymphocytes, we in-
vestigated transgenic mice carrying murine IL-7 cDNA and
SRa promoter. The SRa expression system is shown to be
one or two orders of magnitude more active than SV40
early promoter in a wide variety of cell types including lym-
phoid cells and epithelial cells, and promotes a high level of
expression of various lymphokine cDNAs (17). We estab-
lished transgenic mice carrying murine IL-7 cDNAs by three
promoters, SRa, SV40 early, and metallothionein I (16).
SRa/IL-7 transgenic mice developed severe dermatitis in 7
of 30 founder mice at 4–9 wk of age. However, SV40 early
and metallothionein I/IL-7 transgenic mice never devel-
oped dermatitis in 9-mo observation periods. Interestingly,
some SRa/IL-7 transgenic lines, but not SV40 early/IL-7,
or metallothionein I/IL-7 transgenic mice developed anal
bleeding and rectal prolapse. Therefore, we used the SRa/
IL-7 transgenic mice in this study. The fact that plural
SRa/IL-7 transgenic lines developed rectal prolapse means
that this phenomenon was caused by the transgene itself
and not by the positional effect of the transgene insertion
on chromosome.
In this study, we provide the evidence that SRa/IL-7
transgenic mice developed chronic colitis with perianal bleed-
ing and rectal prolapse. Histological analysis showed ero-
sions, redness, wall thickening with goblet cell-depleted
epithelium, and mononuclear cell infiltration. In the gas-
trointestinal tract, inflammation was limited to the colon
and ileum, and the most severe inflammation occurred in
the rectum. The inflammatory cells then consisted of lym-
phocytes, plasma cells, and macrophages in the IL-7 trans-
genic mice. These mimicked histopathological characteris-
tics of ulcerative colitis in humans (20, 21).
In the IL-7 transgenic mice, the SRa/IL-7 transgene was
constitutively expressed in the thymus, spleen, kidney, brain,
lung, and skin, but not in the liver and muscle as previously
reported (16). Interestingly, development of colitis in the
IL-7 transgenic mice was parallel with the SRa/IL-7 trans-
Figure 5. The expression of
IL-7 mRNA in the colonic mu-
cosa. RT-PCR analysis demon-
strated IL-7 mRNA expression
in normal murine colonic tissues
(A). The specificity of amplified
bands was validated by their pre-
dicted size (496-bp). To ensure
the correct predicted fragments
are present, we digested the am-
plified IL-7 PCR product by re-
striction enzyme EcoRI. 496-bp
PCR products from murine co-
lonic mucosa were digested into
two predicted fragments with
263 and 233 bp. Markers repre-
sented 100-bp DNA ladder. Southern blot analysis confirmed the expression of IL-7 mRNA in normal colonic mucosa (B). PCR products were blotted
onto nylon membrane and hybridized with IL-7 gene-specific cDNA oligonucleotide probe labeled with digoxigenin. IL-7 mRNA expression was de-
tected in the colon, and a detectable expression of IL-7 was in small intestinal tissues and stomach tissues. Markers represented the 100-bp DNA ladder.
For internal standard, amplified bands for G3PDH were used as the housekeeping gene.
Figure 6. Quantity of IL-7 mRNA ex-
pression in the colon and thymus tissues in
the IL-7 transgenic mice. Competitive
PCR demonstrated that 100-fold increase
in IL-7 mRNA transcripts was detected in
the inflamed colonic mucosa of the IL-7
transgenic mice (IL-7 Tg), as compared to
those in wild-type mice (Control). On the
contrary, no difference of the IL-7
mRNA expression was observed in the
thymus tissues between control mice and
IL-7 transgenic mice.397 Watanabe et al.
gene expression in the colonic mucosa. Transgenic mice
with SRa/IL-7 transgene expression in the colonic mucosa
developed colitis, but mice without transgene in the co-
lonic mucosa did not. This result indicated that SRa/IL-7
transgene expression in the colonic mucosa was directly re-
lated to chronic inflammation in the colon of transgenic
mice. It would be interesting to clarify whether the in-
creased expression of the transgene in the colonic mucosa
induces chronic colitis or whether chronic inflammation in
the colonic mucosa induces the activation of the transgene.
However, conclusive evidence has not been easily ob-
tained. The final cumulative frequencies of colitis in the
line 34 IL-7 transgenic mice were not 100%, but 60%. It
was quite difficult or impossible to assess which appears ear-
lier in the same mice, the development of colitis or SRa/
IL-7 transgene mRNA expression in the colonic mucosa.
However, we found that SRa/IL-7 transgene mRNA ex-
pression was not changed in the thymus, spleen, and skin
without dermatitis between mice with colitis and mice
without colitis (Watanabe, M., unpublished observation).
Moreover, we found that 15–20% of transgenic mice with
the SRa/IL-7 transgene mRNA expression in the colonic
mucosa did not develop chronic colitis. The preliminary
histopathological observation of colonic mucosa of these
mice demonstrated that they have little infiltration of mono-
nuclear cells in the lamina propria. On the basis of these
findings, we suggest that the expression of detectable SRa/
IL-7 transgene mRNA in the colonic mucosa is a sign of
developing colitis. However, we cannot deny that after ini-
tiation of colitis by the transgene expression, inflammation
in the colonic mucosa also induces the activation of the
transgene and eventually transgene mRNA expression is
increased.
Southern blot hybridization and competitive PCR dem-
onstrated that expression of IL-7 mRNA was increased in
the inflamed colonic mucosa of the IL-7 transgenic mice.
The distribution of IL-7 mRNA in the colonic tissues was
quite interesting. Analysis of differential expression of IL-7
mRNA showed that colonic mucosal lymphocytes ex-
pressed a significant amount of IL-7 mRNA, but IL-7
mRNA expression in the colonic epithelial cells was un-
changed in the inflamed mucosa. Therefore, increased IL-7
mRNA expression in the inflamed colonic mucosa of IL-7
transgenic mice was derived from the colonic mucosal lym-
phocytes. Interestingly, immunohistochemical analysis dem-
onstrated that IL-7 protein expression in the colonic mu-
cosa and epithelial cells seemed to be decreased at colitis
lesion in the IL-7 transgenic mice. Recent studies demon-
strated that intestinal epithelial cells express IL-7 receptor
and IL-7 regulates the growth and function of epithelial
cells by autocrine or paracrine mechanism (22, 23). Over-
expression of IL-7 in mucosal lymphocytes may lead to the
downregulation of IL-7 protein production in the colonic
epithelial cells. However, our previous study indicated that
IL-7 protein expression by immunohistochemical technique
was demonstrated only in the tissue where secreted IL-7
protein was stored and accumulated (11). Therefore, we as-
sessed IL-7 protein production by isolated cells. Isolated
epithelial cells, IELs, and LPLs form the inflamed colonic
mucosa of IL-7 transgenic mice produced an increased
amount of IL-7. These results indicated that IL-7 produc-
tion and secretion were increased in the inflamed colonic
mucosa of IL-7 transgenic mice in parallel with the increase
of IL-7 mRNA, but accumulation of IL-7 protein in the
colonic mucosa was decreased in the colitis mucosa. We
have shown that intestinal epithelial goblet cells are the ma-
jor source of mucosal IL-7 in the human intestinal mucosa
(11). In this study, goblet cells in the murine colon also
produce IL-7. In the inflamed colonic mucosa of IL-7
transgenic mice, histopathological examination revealed the
depletion of goblet cells. This result is consistent with the
findings that IL-7 protein accumulation was decreased in
the inflamed colonic mucosa of the transgenic mice.
How does mucosal lymphocyte–produced IL-7 in the co-
lonic mucosa of IL-7 transgenic mice affect the proliferation
of mucosal lymphocytes? We have demonstrated IL-7 mRNA
expression and protein production by human colonic epi-
thelial cell line HT29-18-N2 cells after they differentiated
into the goblet cell phenotype (Watanabe, M., unpublished
observation). However, these cell lines produced marginal
Figure 7. Analysis of the dif-
ferential expression of IL-7
mRNA in the colonic mucosa.
PCR analysis demonstrated that
colonic IELs and LPLs isolated
from the inflamed colonic tissues
of IL-7 transgenic mice ex-
pressed a significant amount of
IL-7 mRNA (A). However,
IELs and LPLs from the colonic
tissues of littermate mice showed
no expression of IL-7 mRNA.
Interestingly, competitive PCR
analysis demonstrated that IL-7
mRNA expression in the co-
lonic epithelial cells was not
changed between control mice
and the transgenic mice (B).398 IL-7 Transgenic Mice Develop Chronic Colitis
amounts of IL-7 in the culture supernatants though these
high levels of expressed IL-7 mRNA. The puzzle regarding
the low IL-7 protein production is not specific to the
HT29 sublines. As other investigators discussed (9), almost
all of the cells and cell lines that have been found to pro-
duce IL-7 release IL-7 protein only at low levels. The case
is the most extreme in the human cells, since it was difficult
to detect IL-7 protein production even in the SK-HEP cell
Figure 9. The phenotype of the infiltrating mucosal lymphocytes at the colitis lesion was analyzed by immunohistochemistry. Sections of colonic tis-
sues from IL-7 transgenic mice were stained with anti-CD4 (A) and anti-CD8 (B) antibodies. Lymphoid infiltrates in the lamina propria at the colitis lesion were
dominated by T cells bearing CD41. Both TCR-a/b T cells and g/d T cells infiltrated in the lamina propria of colonic mucosa (data not shown).
Figure 8. Immunohistochemical analysis using rabbit anti–murine IL-7 Ab confirmed IL-7 protein expression in the human intestinal epithelial cells
and epithelial goblet cells. The reactivity of anti–murine IL-7 IgG Ab but not control rabbit IgG is confined to the colonic epithelial cells and epithelial
goblet cells in the normal murine intestinal mucosal tissues (A). Note that biotin-conjugated goat anti–rabbit Ab alone did not show the reactivity. IL-7
protein expression was not changed in the colonic mucosa of IL-7 transgenic mice at 4–6 wk of age (data not shown). However, IL-7 protein expression
seemed to be decreased in the goblet-depleted colonic epithelial cells in the inflamed colonic mucosa of IL-7 transgenic mice at 8–10 wk of age (B).399 Watanabe et al.
line that was used to clone the cDNA for the human IL-7
(24). These observations suggested that IL-7 protein may
be rapidly degraded. Locally produced IL-7 from IELs and
LPLs in the colonic mucosa may be also degraded or inter-
nalized when it does not accumulate in the colonic mucin
of the goblet cells. Therefore, we suggest that accumulation
of IL-7 protein in the mucus of the goblet cells in the co-
lonic mucosa is crucial for regulating the proliferation of
mucosal lymphocytes.
The importance of IL-7 as a mediator of local inflamma-
tory responses remains unclear. However, a possible role
for IL-7 in mucosal inflammation has been recently suggested
by the finding of decreased IL-7 mRNA expression and IL-7
protein accumulation in the colonic epithelium in inflamed
mucosa of patients with ulcerative colitis (Watanabe, M.,
unpublished observation). We have also demonstrated that
IL-7 mRNA expression and IL-7 protein accumulation was
significantly increased in the colonic mucosa of patients with
acute Salmonella infectious colitis, where goblet cell deple-
tion was not observed. In the IL-7 transgenic mice, de-
creased IL-7 protein accumulation in the colonic epithelial
cells was demonstrated after the onset of colitis. These re-
sults favor the idea that the decrease of IL-7 protein accu-
mulation due to the deletion of goblet cells involves the
chronic inflammation of the intestinal mucosa.
Figure 11. Cytokine protein
production by isolated cells from
the chronic inflamed colonic
mucosa of IL-7 transgenic mice
(shaded bars) and from normal
mucosa of normal littermate mice
(white bars). Isolated cells were
cultured and culture supernatants
were analyzed for concentration
of Th1 (IL-2, A; IFN-g, B) and
Th2 (IL-4, C) cytokines by spe-
cific ELISA. Unstimulated lam-
ina propria CD41 T cells from
IL-7 transgenic mice and litter-
mate mice produced marginal
amounts of both IL-2 and IFN-g.
Isolated lamina propria CD41 T
cells from the inflamed colonic
mucosa of IL-7 transgenic mice
produced significantly higher
levels of both IL-2 and IFN-g
than lamina propria CD41 T
cells from littermate mice after
stimulation with anti-CD3 and
anti-CD28 mAbs. In contrast to
Th1 type cytokine production,
secretion of IL-4 by unstimu-
lated lamina propria CD41 T
cells from IL-7 transgenic mice
was identical to lamina propria
CD41 T cells from control litter-
mate mice, and in anti-CD3 and
anti-CD28 mAb-stimulated lam-
ina propria CD41 T cells from
IL-7 transgenic mice, the average secretion of IL-4 was reduced com-
pared with littermate mice. Data represent mean 6 standard error from
three independent experiments done in triplicate. *P ,0.05, statistically
significant as compared with control littermate mice by Mann-Whitney
U test.
Figure 12. Southern blot
analysis demonstrated that IL-7
receptor (IL-7R) mRNA was
not readily detectable in the co-
lonic mucosa from normal litter-
mate mice. However, IL-7 re-
ceptor expression was strongly
detected in the inflamed colonic
mucosa of transgenic mice. The
specificity of the amplified bands
for IL-7 receptor mRNA was validated by their predicted size (600 bp).
Markers represented 100-bp DNA ladder. For internal standard, ampli-
fied bands for G3PDH were used. There was no difference in the expres-
sion of IL-7 receptor in the thymus between IL-7 transgenic mice and
normal littermate mice (data not shown).
Figure 10. The phenotype of the infiltrating intraepithelial lympho-
cytes in the colitis lesion was analyzed by flow cytometric analysis. Flow
cytometric analysis of isolated cells from IEL demonstrated that T cell re-
ceptor g/d IELs were not increased in the IL-7 transgenic mice (IL-7 Tg)
as compared to those in control littermate mice (Control), although g/d T
cells were the main components of mononuclear cells infiltrating in the
dermatitis lesion of IL-7 transgenic mice as previously reported (17).
CD41 T cells, but not CD81 T cells were significantly increased in the
colitis lesions. Moreover, infiltrating CD81 IELs in the IL-7 transgenic
mice expressed mainly a/b heterodimers, indicating that these cells were
thymus dependent. A minimum of 5,000 cells was analyzed for each his-
togram.400 IL-7 Transgenic Mice Develop Chronic Colitis
Lymphoid infiltrates in the lamina propria at the colitis
lesion of IL-7 transgenic mice were dominated by CD41 T
cells. Analysis of cytokine production by anti-CD3 and
anti-CD28 mAb-stimulated lamina propria CD41 T cells
from chronic inflamed colonic mucosa of IL-7 transgenic
mice showed elevated levels of IL-2 and IFN-g produc-
tion. In contrast, IL-4 secreted by those lamina propria T
cells were decreased in IL-7 transgenic mice. These results
indicate that Th1 type CD41 T cells were dominated in
the infiltrating lamina propria T cells in the chronic in-
flamed colonic mucosa of IL-7 transgenic mice. This Th1
pattern of cytokine production from lamina propria CD41
T cells was also observed in the inflamed colonic mucosa of
mice with the hapten reagent 2, 4, 6-trinitrobenzene sul-
fonic acid–induced colitis (19). Flow cytometric analysis of
isolated cells from intraepithelium demonstrated that CD41
T cells, but not CD81 T cells were increased at the colitis
lesions. Interestingly, infiltrating CD81 T cells mainly ex-
pressed the a/b heterodimer, indicating that these cells
were thymus dependent. TCR-g/d intraepithelial T cells
were not increased, although Uehira et al. reported that
transgenic mice constitutively expressing IL-7 developed
severe dermatitis and double negative g/d T cells were the
main components of the infiltrating mononuclear cells at
the dermatitis lesion (16). Recent evidence of an extrathy-
mic pool of TCR-a/b mucosal lymphocytes in the gut
suggests that intestinal epithelial cells may share some dif-
ferentiation-inducing capacities with thymic epithelial cells,
leading to in situ TCR rearrangement of extrathymically
derived T cells (25). We have recently demonstrated the
presence of a novel lymphoid tissue, cryptopatches (CP), in
the murine intestinal mucosa where clusters of IL-7 receptor1
c-kit1 Thy-11 lympho-hematopoietic progenitor developed
in IL-7–dependent fashion (26). These results indicated
that IL-7 may mediate an extrathymic pathway of mucosal
T cell proliferation. Therefore, overexpression of IL-7 pro-
tein in the colitis mucosa of acute stage and decrease of IL-7
protein accumulation in goblet cell–depleted colonic mucosa
of the chronic colitis may disturb IL-7–dependent prolifera-
tion of lymphocytes and progenitors in the mucosal tissues.
We have demonstrated that mucosal T cells in the nor-
mal murine as well as human colonic mucosa constitutively
express the receptor for IL-7. In the present study, IL-7 re-
ceptor mRNA expression was strongly detected in the in-
flamed colonic mucosa of IL-7 transgenic mice, but not
readily detectable in the colonic mucosa from normal lit-
termate mice. Receptor expression was not strong in the
colonic mucosa of transgenic mice without obvious inflam-
mation. These findings indicated that the infiltrating mu-
cosal lymphocytes in the colonic lesion of IL-7 transgenic
mice highly expressed the IL-7 receptor. Interestingly, IL-7
receptor expression was quite marked in the mucosal lym-
phocytes of severely inflamed colonic mucosa from patients
with ulcerative colitis (Watanabe, M., unpublished obser-
vation). These results raise the possibility that decreased
mucosal IL-7 protein accumulation observed in the colonic
mucosa with chronic inflammation of IL-7 transgenic mice
may result in the increase of infiltrating mucosal lympho-
cytes expressing the IL-7 receptor. Previous studies have
shown that IL-7 stimulates the proliferation of human ma-
ture T cells after exogenous stimulation in short time cul-
ture, suggesting that IL-7 receptor is not expressed by rest-
ing PBLs, but expressed after activation. Therefore, our
results indicate that mucosal lymphocytes are activated in
the transgenic mice. These activated T cells may produce
regulatory factors such as cytokines that augment the in-
flammation process.
It has been reported that IL-7 acts synergistically with anti-
CD3 Ab to stimulate proliferation of human T cells in the
thymus and peripheral blood. However, our previous stud-
ies demonstrated that IL-7 inhibited anti-CD3–induced pro-
liferation of mucosal T cells in the normal colonic mucosa.
Moreover, we showed that IL-7 alone inhibited the growth
of mucosal lymphocytes isolated from the inflamed colonic
mucosa (Watanabe, M., unpublished observation). These
suggested that IL-7 may inhibit the proliferation of acti-
vated and IL-7 receptor–expressing mucosal T cells in the
intestinal mucosa.
We are now doing the precise time course studies con-
cerning development of colitis, IL-7 protein expression in
the colonic mucosa, and phenotype of infiltration lympho-
cytes in the IL-7 transgenic mice. IL-7 transgenic mice de-
veloped acute colitis with infiltrating neutrophils and lym-
phocytes at 1–3 wk of age. At that time, IL-7 protein was
significantly expressed in the inflamed colonic mucosa of
IL-7 transgenic mice, but then decreased with depletion of
goblet cells. Accumulation of IL-7 protein in the colonic
mucosa was significantly decreased at 8–12 wk of age. We
also demonstrated that at 1–3 wk of age, infiltrating T
cells in the acute colitis lesion were g/d T cells. This result
is consistent with the findings that g/d T cells were accu-
mulated at the acute dermatitis lesion of IL-7 transgenic
mice (16), and is contrasted with the our findings that a/b
T cells were infiltrated in the chronic colitis lesion of the
IL-7 transgenic mice. Therefore, we supposed that at 1–3
wk, IL-7 transgenic mice developed g/d T cell–mediated
acute colitis due to the overexpression of IL-7 protein, but
with the inflammation IL-7 protein–producing goblet cells
decreased and accumulation of IL-7 protein in the colonic
mucosa decreased in the goblet cell–depleted epithelial cells.
Since we demonstrated that mucosal IL-7 regulates the pro-
liferation of mucosal lymphocytes by apoptotic mechanism
(Watanabe, M., unpublished observation), decreased accu-
mulation of IL-7 protein may lead to the chronic inflam-
mation of colon in the IL-7 transgenic mice. These results
are consistent with our recent findings that IL-7 protein
expression was increased in the inflamed colonic mucosa of
acute Salmonella enterocolitis and initial attack of ulcerative
colitis, but significantly decreased at the chronic colitis le-
sion in the relapsing-remission type and chronic continu-
ous type of ulcerative colitis (Watanabe, M., unpublished
observation).
In this paper, we demonstrate that the dysregulation of
mucosal IL-7–mediated immune regulation results in the
acute and chronic colitis in IL-7 transgenic mice. This colitis
mimicked several histopathological characteristics of ulcer-401 Watanabe et al.
ative colitis in humans. A major limitation in understanding
the pathogenesis responsible for the mucosal injury ob-
served in human inflammatory bowel disease has been due
to the lack of animal models that possess the histopatholog-
ical features of human disease. A series of valuable new
models that spontaneously arise in gene knockout mice
gives a major impact in our understanding of the mecha-
nisms that lead to chronic intestinal inflammation (27–29).
Although the mechanism by which these mice developed
chronic colitis is unclear, series of the study using these
mice and our IL-7 transgenic mice may lead to the under-
standing of the pathogenesis of human inflammatory bowel
disease.
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